Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023
PR Newswire Asia
SHANGHAI, March 28, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company..
SHANGHAI, March 28, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company..
– Analysis further supports obesity-associated dysregulated aldosterone as an endotype predictive of enhanced response to..
- Results from the largest European and first multicenter, retrospective, observational chart review study investigating the..